In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Luye Pharma Group, Ltd.

http://www.luye.cn/lvye_en

Latest From Luye Pharma Group, Ltd.

Strong Sales, Deals Propel China Biotechs To 2023 Profitability

Strong sales growth and licensing activity in 2023 helped multiple Chinese biotechs to a solid profit performance, some moving into the black for the first time.

China Sales & Earnings

Enzene CEO On Biosimilar Denosumab And Cetuximab; Medicare Negotiation Impact On US Market

CEO of Enzene Biosciences weighs in on the impact of Medicare negotiations in the US on the biosimilars market even as a US filing is planned for a Prolia biosimilar. In the interview, he says Enzene “is not afraid or concerned” over ongoing litigation with Merck KGaA over an Erbitux biosimilar in India, adding that new modalities like ADCs are being “seriously” considered.

Business Strategies Commercial

Boan Biotech Begins International Phase III Trial Of Denosumab Biosimilars

Having already launched one of its denosumab biosimilar products in China, Boan Biotech has now commenced an international Phase III study to secure approval in Europe, the US and Japan.

Clinical Trials Biosimilars

With Prolia Rival In The Bag, China’s Luye Takes Aim At Xgeva Biosimilar

Boan Biotech is continuing its ascent in Chinese biosimilars by filing another product with the country’s regulator.

Biosimilars Regulation
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Transdermal
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Beijing WBL Peking University Biotech Co., Ltd
    • Nanjing Luye Sike Pharma Co., Ltd
    • Shandong Luye Pharmaceutical Co., Ltd
    • Sichuan Luye Baoguang Pharmaceutical Industry Co., Ltd
    • Shandong Boan Biological Technology Co. Ltd.
UsernamePublicRestriction

Register